The anticoagulant Eliquis may cause internal bleeding that cannot be stopped, putting patients at risk for a life-threatening hemorrhage. Lawsuits are being filed against drugmakers Bristol-Myers Squibb and Pfizer. The Dugan law Firm is accepting clients who took Eliquis and suffered injuries.
Eliquis is potentially more dangerous than warfarin, a drug that was the industry-standard blood thinner for decades. Because they reduce blood clotting, all blood thinners can cause bleeding. The new generation of blood thinners are marketed as alternatives to warfarin that offer benefits over the older treatment, including no routine blood testing and no major dietary restrictions. However, while regular anticoagulation blood tests may be seen as burdensome to patients, research suggests that measuring coagulation function can help assess bleeding risk.
Eliquis is marketed as producing less major bleeding than warfarin; however, major bleeding with warfarin can be reversed with Vitamin K, but Eliquis does not have an antidote to stop bleeding, so once an Eliquis patient experiences serious bleeding, a doctor may not be able to control or stop it.
Eliquis may cause internal bleeding that is serious, irreversible, and potentially fatal. Risks include:
- Gastrointestinal bleeding
- Kidney bleeding
- Rectal bleeding
- Eye bleeding
- Spinal bleeding
- Cerebral hemorrhage